Health Care Higher on Reports of Juno Deal Talks -- Health Care Roundup

Features Dow Jones Newswires

Shares of health-care companies rose on deal speculation.

Continue Reading Below

Cancer-treatment developer Juno Therapeutics shares surged after reports it was in deal talks with larger biotech company Celgene.

Exelixis, another oncology-focused biotech, said a liver-cancer therapy showed promise in a clinical trial.

Rob Curran, rob.curran@dowjones.com

(END) Dow Jones Newswires

January 17, 2018 17:16 ET (22:16 GMT)